COVAXX, a division of United Biomedical, is responding to the COVID-19 breakout in a manner that is consistent with our values by following the science and putting diagnostics and solutions-thinking at the center of our approach. Our priority is to stay on the front lines to safeguard the health and well-being of our communities.
We have already deployed our antibody tests in several states in the U.S., China, and Taiwan. We are a high throughput antibody test and are actively working with communities and institutions to help detect and contain community spread.
In addition, COVAXX is developing the first Multitope Peptide-Based Vaccine that has shown promising efficacy in animals and is based on a commercially proven, safe and scalable vaccine platform. We are entering human trials later this summer.
Our mission and vision is to save and safeguard lives by tackling the global COVID-19 pandemic using cost-effective, scalable, and proven science-based solutions delivered to the world.
No products posted yet
No services posted yet
This service is currently only supported on the desktop screens, please, use this service from your desktop or laptop for correct visualization and functionality